Personalized screening for breast cancer: A Wolf in sheep's clothing?

American Journal of Roentgenology

Volumn 205, Issue 6, 2015, Pages 1365-1371

  Feig, Stephen A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Risk based screening

Indexed keywords

RALOXIFENE; TAMOXIFEN;

AGE; BREAST BIOPSY; BREAST CANCER; BREAST DENSITY; CANCER RISK; CANCER SCREENING; EATING HABIT; ECHOMAMMOGRAPHY; EXERCISE; FAMILY HISTORY; GENE MUTATION; HIGH RISK PATIENT; HUMAN; LIFESTYLE MODIFICATION; MAMMOGRAPHY; MASTECTOMY; MEDICAL DECISION MAKING; MEDICAL SOCIETY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK MANAGEMENT; TUMOR SUPPRESSOR GENE; WEIGHT REDUCTION; ADULT; AGED; BREAST TUMOR; ECHOGRAPHY; FEMALE; MIDDLE AGED; RADIOGRAPHY; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PRECISION MEDICINE; RISK ASSESSMENT; RISK FACTORS; ULTRASONOGRAPHY, MAMMARY;

EID: 84948783461     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.15.15293     Document Type: Note

References (83)

1. Lee CH, Dershaw D, Kopans D, et al. Breast cancer screening with imaging: recommendation from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010; 7:18-27
2. Mainiero MB, Loarenco A, Mahoney MC, et al. ACR Appropriateness Criteria breast cancer screening. J Am Coll Radiol 2013; 10:11-14
3. Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2015; 65:30-54
4. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57:75-89
5. Berg WA, Blume JD, Cormack JB, et al.; ACRIN 6666 Investigators. Combined screening with ultrasound and mammography vs mammography in women at elevated risk of breast cancer. JAMA 2008; 299:2151-2163
6. Berg WA, Zhang Z, Lehrer D, et al.; ACRIN 6666 Investigators. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 2012; 307:1394-1404
7. Feig SA, Reitherman R, Pruthi S. Dense breast tissue: the emerging role of supplementary screening. ARRS InPractice 2013; 7:15-17
8. Brem RF, Tabár L, Duffy SW, et al. Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study. Radiology 2015; 274:663-673
9. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med 2011; 155:10-20
10. van Ravesteyn NT, Miglioretti DL, Stout NK, et al. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med 2012; 156:609-617
11. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008; 148:337-347
12. O'Donoghue C, Eklund M, Ozanne EM, Esserman LJ. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med 2014; 160:145-153
13. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 2014; 311:1327-1335
14. Onega T, Beaber EF, Sprague BL, et al. Breast cancer screening in an era of personalized regimens. Cancer 2014; 120:2955-2964
15. Vilaprinyo E, Forne C, Carles M, et al.; Interval Cancer (INCA) Study Group. Cost-effectiveness and harm-benefit analysis of risk-based screening strategies for breast cancer. PLoS One 2014; 9:e86858
16. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 151:716-726
17. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009; 151:738-747
18. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151:727-737
19. Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR 2011; 196:[web]W112-W116
20. Masarwah A, Auvinen P, Sudah M, et al. Very low mammographic breast density predicts poorer outcome in patients with breast cancer. Eur Radiol 2015; 25:1875-1882
21. Sala E, Warren R, McCann J, et al. Mammographic parenchymal patterns and breast cancer natural history: a case-control study. Acta Oncol 2001; 40:461-465
22. Moskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology 1986; 161:37-41
23. Tabár L, Fagerberg G, Day NE, Holmberg L. What is the optimal interval between screening examinations? An analysis based on the Swedish two-county breast cancer screening trial. Br J Cancer 1987; 55:547-551
24. Feig SA. Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years. Cancer 1995; 75:2412-2419
25. Feig SA. Determination of mammographic screening intervals with surrogate measures for women aged 40-49 years. Radiology 1994; 193:311-314
26. Duffy SW, Day NE, Tabár L, Chen HH, Smith RA. Markov models of breast tumor progression: some age-specific results. J Natl Cancer Inst Monogr 1997; 22:93-97
27. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995; 56:265-271
28. Frykberg ER. Lobular carcinoma in situ of the breast. Breast J 1999; 5:296-303
29. Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 1993; 71:1258-1265
30. Page DL, Schuyler PA, Dupont WD, et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003; 361:125-129
31. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001; 358:1389-1399
32. Easton DF. Familial risks of breast cancer. Breast Cancer Res 2002; 4:179-181
33. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347:1233-1241
34. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15:36-47
35. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: The Nurses' Health Study. Am J Epidemiol 1994; 139:819-835
36. Shapiro S, Venet W, Strax P, et al. Periodic screening for breast cancer: the Health Insurance Plan project and its sequelae. Baltimore, MD: Johns Hopkins Press, 1988:96-99
37. Shapiro S, Goldberg J, Venet L, et al. Risk factors in breast cancer: a prospective study. In: Doll R, Bodopija I, eds. Host environmental interactions in the etiology of cancer in man. Lyon, France: International Agency for Research on Cancer, 1973:169-182
38. Solin L, Schwartz G, Feig S, et al. Risk factors as criteria for inclusion in breast cancer screening programs. In: Ames F, Blumenschein O, Montague E, eds. Current controversies in breast cancer. Austin, TX: University of Texas Press, 1984:565-572
39. Alexander FE, Roberts MM. The menopause and breast cancer. J Epidemiol Community Health 1987; 41:94-100
40. Alexander FE, Roberts MM, Huggins A. Risk factors for breast cancer with applications to selection for the prevalence screen. J Epidemiol Community Health 1987; 41:101-106
41. De Waard F, Collette JG, Rombach JJ, et al. Breast cancer screening with particular reference to the concept of 'high risk' groups. Breast Cancer Res Treat 1988; 11:125-132
42. Paci E, Del Turco MR, Palli D, et al. Selection of high-risk groups for breast cancer screening: evidence from an Italian multicentric case control study. Tumori 1988; 74:675-679
43. Destounis SV, Arieno AL, Morgan RC, et al. Comparison of breast cancers diagnosed in screening patients in their 40s with and without family history of breast cancer in a community outpatient facility. AJR 2014; 202:928-932
44. Arleo EK, Dashevsky BZ, Reichman M, et al. Screening mammography for women in their 40s: a retrospective study of the potential impact of the U.S. Preventive Service Task Force's 2009 breast cancer screening recommendations. AJR 2013; 201:1401-1406
45. Keedy AW, Price ER, Gidwaney R, Sickles EA, Joe BN. The potential impact of risk-based screening mammography in women 40-49 years old. AJR 2015 Jul 23 [Epub ahead of print]
46. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR 1976; 126:1130-1137
47. Egan RL, Mosteller RC. Breast cancer mammography patterns. Cancer 1977; 40:2087-2090
48. Boyd NF, O'Sullivan B, Fishell E, et al. Mammographic patterns and breast cancer risk: methodologic standards and contradictory results. J Natl Cancer Inst 1984; 72:1253-1259
49. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356:227-236
50. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995; 87:670-675
51. Boyd NF, Martin LJ, Sun L, et al. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15:2086-2092
52. Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995; 87:1622-1629
53. Ursin G, Ma H, Wu AH, et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003; 12:332-338
54. Vacek PM, Geller BM. A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev 2004; 13:715-722
55. Nelson HD, Zakber B, Cantor A, et al. Risk factors for breast cancer in women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 2012; 156:635-648
56. D'Orsi CJ, Bassett LW, Berg WA, et al. BI-RADS: mammography, 4th ed. In: D'Orsi CJ, Mendelson EB, Ikeda DM, et al. Breast Imaging Reporting and Data System: ACR BI-RADS-breast imaging atlas. Reston, VA: American College of Radiology, 2003:179-189
57. Sickles, EA, D'Orsi CJ, Bassett LW, et al. ACR BI-RADS mammography. In: ACR BI-RADS atlas, Breast Imaging Reporting and Data System. Reston, VA: American College of Radiology, 2013:123-126
58. Kerlikowske K, Grady D, Barclay J, et al. Vari-ability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst 1998; 90:1801-1809
59. Nicholson BT, Lo Russo AP, Smolkin M, et al. Accuracy of assigned BI-RADS breast density definitions. Acad Radiol 2006; 13:1143-1149
60. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81:1879-1886
61. Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994; 86:600-607
62. Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999; 91:1541-1548
63. Bondy ML, Lustbader ED, Halabi S, et al. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994; 86:620-625
64. Breast Cancer Surveillance Consortium website. Breast Cancer Surveillance Consortium risk calculator. tools.bcsc-scc.org/BC5yearRisk/calculator.htm. Accessed August 14, 2015
65. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991; 48:232-242
66. McGuigan KA, Ganz PA, Breant C. Agreement between breast cancer risk estimation models. J Natl Cancer Inst 1996; 88:1315-1317
67. McTiernan A, Kuniyuki A, Yasui Y, et al. Comparison of two breast cancer risk estimates in women with a family history of breast cancer. Cancer Epidemiol Biomarkers Prev 2001; 10:333-338
68. Parmigiani G, Berry DA, Aquilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998; 62:145-158
69. Jonker MA, Jacobi CE, Hoogendoorn WE, Nagelkerke NJ, de Bock GH, van Houwelingen JC. Modeling familial clustered breast cancer using published data. Cancer Epidemiol Biomarkers Prev 2003; 12:1479-1485
70. Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast cancer and ovarian cancer. Br J Cancer 2004; 91:1580-1590
71. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004; 23:1111-1130
72. Amir E, Evans DG, Shenton A, et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 2003; 40:807-814
73. Jacobi CE, de Bock GH, Siegerink B, Van Asperen CJ. Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? Breast Cancer Res Treat 2009; 115:381-390
74. Cummings SR, Tice JA, Bauer S, et al. Prevention of breast cancer in post-menopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 2009; 101:384-398
75. Kopans DB. Basic physics and doubts about relationship between mammographically determined tissue density and breast cancer risk. Radiology 2008; 246:348-353
76. Molloi S, Ding H, Feig S. Breast density evaluation using spectral mammography, radiologist reader assessment, and segmentation techniques: a retrospective study based on left and right breast comparison. Acad Radiol 2015; 22:1052-1059
77. Newman B, Austin MA, Lee M, King M. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 1988; 85:3044-3048
78. King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302:643-646
79. Pharoah PDP, Antoniou AC, Easton DF. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 2008; 358:2796-2803
80. Pharoah PDP, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BAJ. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002; 31:33-36
81. Wacholder S, Hartge P, Prentice R, et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med 2010; 362:986-993
82. Michailidou K, Hall P, Gonzalez-Neira A, et al. Large-scale genotyping identifies 4 new loci associated with breast cancer. Nat Genet 2013; 45:353-361
83. Easton DF, Pooley KA, Dunning AM, et al. Genomewide association study identifies novel breast cancer susceptibility loci. Nature 2007; 447:1087-1093